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Schinus terebinthifolius Raddi (Anacardiaceae), popularly known as red aroeira, is used in traditional medicine to treat
inflammatory, gastric, and respiratory disorders.The aimof this studywas to evaluate the antihistaminic activity of S. terebinthifolius
(St) bark extract by using in vivo and in vitro experimental models. The effects of St were investigated on contractions induced by
histamine, carbachol, and potassium chloride in isolated guinea pig ileum. St was also studied in response to hind paw edema
induced by histamine in rats. Experiments revealed that although St (250, 500, and 1,000 𝜇g/mL) reduced the histamine-induced
contractions by 9.1 ± 1.8, 50.2 ± 2.0, and 68.9 ± 2.0%, respectively, it did not inhibit contractions induced by carbachol or KCl. The
association of St (250 and 500 𝜇g/mL) with hydroxyzine, an H1-antihistamine (0.125 and 0.250 𝜇M), increased the inhibitory effect
to 67.0±3.2 and 85.1±2.1%, respectively. Moreover, St (100, 200, and 400mg/kg) decreased paw edema from its peak by 33.9, 48.4,
and 54.8%, respectively, whereas hydroxyzine (70mg/kg) inhibited the peak edema by 56.5%. Altogether, the results suggest that
the bark extract of S. terebinthifolius has an antihistaminic effect (H1).
1. Introduction
The increased prevalence of certain allergic diseases in
several countries during the past few decades represents a
majormedical problemworldwide. Lifelong, progressive, and
severe, such diseases are also associated with mortality and
significant morbidity.
Allergies are common diseases that affect humans with
diverse manifestations. They can induce several types of
immune reactions, including type-I hypersensitivity reac-
tions and the activation of mast cells [1, 2], the latter of which
are key causes of allergic inflammation. Briefly, the release of
histamine from activatedmast cells and basophils contributes
significantly to symptoms of rhinitis, sinusitis, conjunctivitis,
urticaria, and other allergic reactions, including angioedema,
asthma, anaphylaxis, and contact dermatitis [3].
Histamine is the most characterized and potent vasoac-
tive mediator implicated in the acute phase of hypersen-
sitivity. Its release can induce smooth muscle contraction,
vasodilatation, and increased vascular permeability, among
other conditions [4, 5]. Currently, four human G-protein-
coupled histamine receptor subtypes (H1–4) are known to
mediate the various actions of themonoamine.Thehistamine
H1 receptor has been an attractive target for drug discovery
Hindawi
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 1416375, 10 pages
https://doi.org/10.1155/2017/1416375
2 Evidence-Based Complementary and Alternative Medicine
for several years, and H1 receptor antagonists have proven
to be effective therapeutic agents for allergy and respiratory
disorders [6].
The Brazilian pepper tree, or read aroeira (Schinus
terebinthifolius Raddi, Anacardiaceae), is a perennial plant
native to Latin America and widely found in northeast Brazil
[7]. In folk medicine, its aqueous bark extract is used to
treat gastric ulcers [8], and it is also popularly used as
an antiseptic, anti-inflammatory, balsamic, and hemostatic
agent [9]. The importance of the plant has prompted its
inclusion in Brazilian pharmacopoeia, inwhich the decoction
of its bark is used as an anti-inflammatory agent [10].
The species has been frequently studied from a chemical
viewpoint, and the presence of several constituents has been
established, including phenols [11], pentagalloylglucose (i.e.,
a precursor of many complex structures of tannins) [12],
and flavonoids [13, 14]. Chemical analysis of the bark of S.
terebinthifolius has revealed the presence of anthraquinones,
flavonoids, xanthones, saponins, pentacyclic triterpenes, and
free steroids [15].
The increased incidence of allergic diseases in the human
population has stimulated the search for bioactive products
with potential antihistamine activity [16, 17]. In contribution,
the aim of this study was to evaluate the antihistaminic
activity of S. terebinthifolius bark extract by using in vivo and
in vitro experimental models.
2. Material and Methods
2.1. Plant Material and Extraction. Bark from the stem of
S. terebinthifolius Raddi was collected in the remains of the
Atlantic rainforest located in the municipality of Cabo de
Santo Agostinho, Pernambuco, Brazil (8∘ 20󸀠 33󸀠󸀠 S, 34∘ 56󸀠
59󸀠󸀠W) in May 2013. A voucher specimen was authenticated
in the Department of Botany at the Federal University of
Pernambuco by curatorM. Barbosa and deposited at Geraldo
Mariz Herbarium (number 8758). Extraction was performed
by the maceration of 250 g of pulverized S. terebinthifolius
bark in 500mL of 70% ethanol, at room temperature for 7 d.
Crude ethanolic extract was filtered and evaporated under
reduced pressure at 45∘C for the complete elimination of the
alcohol, followed by lyophilization, yielding approximately
17,4 g of dry residue. The lyophilized extract of S. terebinthi-
folius was kept at room temperature until use and suspended
in distilled water.
2.2. High-Performance Liquid Chromatography Analysis. The
chief phytochemical markers (i.e., gallic acid, ellagic acid,
catechin, and epicatechin) in S. terebinthifolius samples were
analyzed by liquid chromatography-diode array detection
(LC-DAD) analysis using a HPLC system (LC-20AT, Shi-
madzu, Kyoto, Japan) equipped with a photodiode array
detector (SPD-M20A, Shimadzu, Kyoto, Japan). Chromato-
graphic separation was performed using a Gemini RP-18 col-
umn (5𝜇mparticle size and 250×4.60mm i.d.; Phenomenex,
Torrance, CA, USA) protected by a guard column of the same
material.
Gradient elution was performed by varying the propor-
tion of solvent A (0.5% acetic acid in distilled water, v/v) and
solvent B (methanol) at a flow rate of 0.8mL/min following a
gradient program of 20–40% B (10min), 40–60% B (10min),
60% B (10min), 60–40% B (10min), and 40–20% B (10 min).
The dried extracts and standards were dissolved in methanol:
water (20 : 80, v/v) and filtered through a membrane of
0.45 𝜇m (Millipore, Billerica, MA, USA) prior to injection
of 20𝜇L. The peaks of each marking on dry substance were
identified by comparing retention times and UV spectra of
DAD.
2.3. Animals. Adult guinea pigs (Cavia porcellus) weighing
350–500 g and Wistar rats (Rattus norvegicus) weighing
250–300 g of both sexes, obtained from the Department
of Physiology and Pharmacology at the Federal University
of Pernambuco, were used for the in vitro and in vivo
experiments, respectively. The animals had free access to
standard food and water and were kept in separate rooms
at 22 ± 2∘C with 55–65% humidity with a 12 h light-dark
cycle. All experimental protocols were submitted to and
approved by the Animal Experimentation Ethics Committee
of the Federal University of Pernambuco (license number
045543) in accordance with the National Institutes of Health’s
(Washington, DC, 2011) Guide for the Care and Use of
Laboratory Animals.
2.4. Solutions and Drugs. In experiments, potassium chlo-
ride (KCl), histamine dihydrochloride, carbamylcholine
chloride (carbachol), hydroxyzine dihydrochloride, vera-
pamil hydrochloride, and 2-pyridylethylamine were manu-
ally diluted in distilled water and added to the organ bath.
The nutrient solution used was modified Krebs solution
with the composition (in mM) NaCl (117.0), NaHCO3 (25.0),
NaH2PO4 (1.2), CaCl2 (2.5), KCl (4.7), MgSO4 (1.3), and
glucose (11.0), pH = 7.4. Drugs were purchased from Sigma-
Aldrich (St. Louis, MO, USA) and Vetec (Rio de Janeiro, RJ,
Brazil).
2.5. Measurement of Ileum Contractile Activity. The experi-
ment was performed by using the method described by Neto
[16]. After fasting for 18 h, with water available ad libitum, the
guinea pigs were euthanized by CO2 inhalation. The ileum
was immediately removed, cleaned of connective tissue,
and immersed in nutrition solution at room temperature.
Roughly 2 cm long segments of the ileum were individually
suspended in a 5mL organ bath containing modified Krebs
solution at 37∘C and continuously gassed with a carbogenic
mixture (95% O2 and 5% CO2). With the tissues oriented
along their longitudinal axes, one side of the tissue was fixed
to the bath and the other connected to a force transducer
in order to measure isometric tension. The segments were
allowed to stabilize for 30min under a resting tension of 1 g.
Thereafter, the preparations were washed every 10min. The
contractions were measured using force transducers coupled
to an amplifier (AECAD 04F, AVS Projects, Sa˜o Paulo, Brazil)
connected to a computer with AQCAD 2.0.4 software (AVS
Projects).
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2.6. Experimental Protocols
2.6.1. Effect of S. terebinthifolius Bark Extract on Contractions
Induced by Histamine, Carbachol, and KCl. After the stabi-
lization period, two submaximal contractions of the extract
(selected from concentration-response curves) of similar
amplitude were induced by an agonist of histamine recep-
tors (histamine, 1 𝜇M), an agonist of muscarinic receptors
(carbachol, 1 𝜇M), or a membrane depolarizing agent (KCl,
40mM) at intervals of 30 min. The second contraction was
defined as the control (100%). Thereafter the extract of S.
terebinthifolius (250, 500, and 1,000𝜇g/mL) was added to the
bath; each preparationwas exposed to only one concentration
of the extract. After an incubation period of 20min, a new
contraction was induced by the contractile agent in the
presence of the extract, and the amplitude of the contraction
was measured.
2.6.2. Effect of Hydroxyzine on Contractions Induced by His-
tamine, Carbachol, and KCl. After the appropriate stabiliza-
tion of the preparations, the ileum was contracted two times
with histamine (1𝜇M), carbachol (1 𝜇M), or KCl (40mM) at
intervals of 30min. The second contraction was defined as
the control (100%). Then hydroxyzine (0.125 and 0.250 𝜇M),
a H1-antihistamine, was added to the bath; each preparation
was exposed to only one concentration of hydroxyzine. After
an incubation period of 20min, a new contraction was
induced by the contractile agent in the presence of the H1-
antihistamine.
2.6.3. Effect of Verapamil on Contractions Induced by His-
tamine, Carbachol, and KCl. After the stabilization period,
two contractions with similar amplitude were obtained by
histamine (1 𝜇M), carbachol (1 𝜇M), or KCl (40mM) at
intervals of 30min. The second contraction was defined as
the control (100%). Once verapamil (0.350 and 0.700 𝜇M),
a voltage-activated calcium channel blocker, was added to
bath, each preparationwas exposed to only one concentration
of verapamil. After an incubation period of 20min, a new
contraction was induced by the contractile agent in the
presence of verapamil.
2.6.4. Effect of theAssociation of S. terebinthifolius Bark Extract
and Hydroxyzine on Contractions Induced by Histamine.
After the appropriate stabilization of the preparations, the
ileum was contracted two times with histamine (1𝜇M) at
intervals of 30min.The second contractionwas defined as the
control (100%). Once hydroxyzine plus S. terebinthifolius bark
extract (0.125 + 250 and 0.250 𝜇M+500 𝜇g/mL)was added to
bath, each preparationwas exposed to only one concentration
of the mixture. After an incubation period of 20min, a third
contraction was induced by histamine.
2.6.5. Effect of S. terebinthifolius Bark Extract, Hydroxyzine,
or Their Association on the Concentration-Effect Curve to His-
tamine. Following the stabilization period, two contractions
of similar amplitude were elicited by histamine (1𝜇M) at
intervals of 30min. The second contraction was defined as
the control (100%). The preparations were incubated with
S. terebinthifolius bark extract (250, 500, and 1,000 𝜇g/mL),
hydroxyzine (0.125 and 0.250 𝜇M), or hydroxyzine plus S.
terebinthifolius bark extract (0.125 + 250 and 0.250 𝜇M +
500 𝜇g/mL). After an incubation period of 20min, histamine
was cumulatively added to bath (10−9 up to 10−4M), and a
concentration-effect curve was obtained.
2.6.6. Effect of S. terebinthifolius Bark Extract on the Concen-
tration-Effect Curve to 2-Pyridylethylamine. Following the
stabilization period, two contractions with similar scope
were elicited by the H1 selective agonist 2-pyridylethylamine
(2-PEA) at intervals of 30min. The second contraction
was defined as the control (100%). Once the preparations
were incubated with S. terebinthifolius bark extract (250,
500, and 1,000 𝜇g/mL), each was exposed to only one
concentration of the extract. After an incubation period
of 20min, 2-pyridylethylamine was cumulatively added to
bath (10−8–10−4M), and a concentration-effect curve was
obtained.
2.7. Histamine-Induced Paw Edema in Rats. Doses of the
extract were based on the study of Cavalher–Machado et al.
[12]. The experiment was performed by using the method
of Winter et al. [18] with slight modifications. After 12 h of
fasting, Wistar rats were randomly divided into five groups
(𝑛 = 3/sex/group). The first group received drinking water
(10mL/kg p.o.), whereas the second was treated with hydrox-
yzine (70mg/kg, p.o.). The other groups were orally treated
with S. terebinthifolius bark extract (100, 200, and 400mg/kg,
per os, respectively). Approximately 1 h after the treatments,
edema was induced by the administration of histamine
(0.1%w/v, 0.1mL) in the right-hind paw’s subplantar region.
The results were obtained by the paw’s volume difference
before and after 0.5, 1, 2, 3, and 4 h of edema induction. Paw
volumewasmeasured by plethysmography (Model 7140, Ugo
Basile, Varese, Italy).
2.8. Statistical Analysis. Results were expressed as mean ±
SEM. Differences between means were determined using
one-way analysis of variance followed by Tukey’s multiple
comparisons test. The level of significance for rejection of the
null hypothesis was 5% (𝑝 < 0.05). The concentration of
a substance that reduces the response to an agonist by 50%
(IC50) was obtained by nonlinear regression. The maximum
effect and negative logarithm of the molar concentration of
an agonist that produces 50% of its maximal effect (pEC50)
were obtained graphically from the concentration-response
curve. Analyses were performed using GraphPad Prism 6.0
(GraphPad Software, Inc., La Jolla, CA, USA).
3. Results
3.1. Phytochemical Screening of S. terebinthifolius Bark Extract.
The LC-DAD for the chemical identification of the con-
stituents of S. terebinthifolius bark extract revealed the pres-
ence of chromatographic peaks consistent with the standards.
The retention times were 4.66, 7.51, 10.24, and 19.05min for
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Figure 1: Chromatogram of Schinus terebinthifolius (St) bark extract detected at 278 nm. Peaks: (1) gallic acid (Rt = 4.66), (2) catechin (Rt =
7.51), (3) epicatechin (Rt = 10.24), and (4) ellagic acid (Rt = 19.05).
gallic acid, catechin, epicatechin, and ellagic acid, respectively
(Figure 1).
3.2. Effect of S. terebinthifolius Bark Extract on Contractions
Induced by Histamine, Carbachol, and KCl. S. terebinthi-
folius selectively inhibited contractions induced by histamine
(1 𝜇M) in guinea pig ileum in a concentration-dependent
manner. The reductions were 9.1 ± 1.8, 50.2 ± 2.0, and 68.9 ±
2.0% (𝑝 < 0.05) with doses of 250, 500, and 1,000 𝜇g/mL
of the extract, respectively (n = 6). IC50 (95% CI) was
487.5𝜇g/mL (460.3–517.6 𝜇g/mL). By contrast, the extract at
the same concentrations showed no effect on carbachol- or
KCl-induced contractions (Figure 2).
3.3. Effect of Hydroxyzine on Contractions Induced by His-
tamine, Carbachol, and KCl. Hydroxyzine decreased the
amplitude of histamine-induced contractions by 25.9 ± 3.1
and 51.2 ± 3.0% (𝑝 < 0.05) in concentrations of 0.125
and 0.250 𝜇M, respectively (𝑛 = 6). Similar to the extract,
hydroxyzine (0.250 𝜇M) showed no effect on the carbachol-
or KCl-induced contractions. The percentage of contractions
induced by carbachol and KCl was 100.4 ± 2.1 and 102.3 ±
1.6%, respectively.
3.4. Effect of Verapamil on Contractions Induced byHistamine,
Carbachol, and KCl. Verapamil (0.350 𝜇M) decreased the
amplitude of contractions induced by histamine and carba-
chol by 52.0 ± 4.3 and 54.8 ± 2.3% (𝑝 < 0.05), respectively,
whereas contractions elicitedwithKCl reduced by 56.3±2.9%
(𝑝 < 0.05) in a concentration of 0.700 𝜇M (n = 6).
3.5. Effect of the Association of S. terebinthifolius Bark Extract
and Hydroxyzine on Simple Contractions Induced by His-
tamine. Theassociation of S. terebinthifolius and hydroxyzine
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Figure 2: Effect of Schinus terebinthifolius (St) bark extract on the contractions induced by histamine (1 𝜇M; (a)), carbachol (1 𝜇M; (b)), and
KCl (40mM; (c)) in isolated guinea pig ileum. Columns and vertical bars represent the mean ± SEM, respectively (𝑛 = 6). ∗Statistically
different from control. #Significant difference (one-way ANOVA followed by Tukey’s multiple comparisons test, 𝑝 < 0.05).
induced an increase in the inhibitory effect of histamine-
induced contractions compared to the inhibition produced
by the extract or hydroxyzine alone. Reductions of 67.0±3.2%
and 85.1 ± 2.1% (𝑝 < 0.05) occurred with 250 + 0.125 and
500 𝜇g/mL + 0.250𝜇Mof S. terebinthifolius plus hydroxyzine,
respectively (𝑛 = 6), as shown in Figure 3.
3.6. Effect of S. terebinthifolius Bark Extract, Hydroxyzine,
or Their Association on the Concentration-Effect Curve to
Histamine. At concentrations of 250, 500, and 1,000𝜇g/mL,
S. terebinthifolius rightward shifted histamine curves com-
pared to the control 7.3, 9.7, and 11.6 times, respectively. The
two highest concentrations of the extract (Figure 4(a)) also
reduced the maximum effect (𝐸max) of histamine. Hydrox-
yzine also induced a shift to the right of the concentration-
effect curves of histamine, with a decrease in maximal effect.
The shiftwas 13.0 and 15.2 times that of the control in the pres-
ence of 0.125 and 0.250𝜇Mof hydroxyzine, respectively (Fig-
ure 4(b)). The effects were even greater when the extract was
associated with hydroxyzine, which shifted the curves to the
right 16.2 and 18.9 times in concentrations of 250 + 0.125 and
500 𝜇g/mL + 0.250 𝜇Mof S. terebinthifolius plus hydroxyzine,
respectively (Figure 4(c)). Results in pharmacological param-
eters 𝐸max and pEC50 appear in Table 1, which shows that the
S. terebinthifolius (500 𝜇g/mL), hydroxyzine (0.250 𝜇M), and
S. terebinthifolius plus hydroxyzine (500𝜇g/mL + 0.250 𝜇M)
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Table 1: 𝐸max and pEC50 values of concentration-response curves to histamine in the absence and presence of Schinus terebinthifolius (St)
bark extract, hydroxyzine (HXZ), and their associations.
Treatment 𝐸max (%) pEC50
Control 99.0 ± 1.4 7.37 ± 0.03
St 250 𝜇g/mL 94.7 ± 1.6 6.64 ± 0.05∗
St 500 𝜇g/mL 65.7 ± 1.9∗ 6.40 ± 0.04∗,#
St 1,000𝜇g/mL 49.4 ± 2.5∗ 6.21 ± 0.07∗
HXZ 0.125 𝜇M 86.6 ± 2.5∗ 6.07 ± 0.05∗
HXZ 0.250 𝜇M 72.9 ± 3.6∗ 5.85 ± 0.06∗,#
St 250 𝜇g/mL + HXZ 0.125 𝜇M 75.7 ± 3.2∗ 5.75 ± 0.05∗
St 500 𝜇g/mL + HXZ 0.250 𝜇M 58.4 ± 3.7∗ 5.48 ± 0.05∗,#
Values represent the mean ± SEM (𝑛 = 6). ∗Statistically different compared to the control. #The groups are statistically different from each other. (One-way
ANOVA followed by Tukey’s multiple comparisons test, 𝑝 < 0.05.)
St (g/mL)
Control 250 500
HXZ (M)
0.125 0.250
St (g/mL) + HXZ (M)
250 + 0.125 500 + 0.250
#
#
#
#
∗
∗
∗
∗
∗
∗
0
25
50
75
100
C
on
tr
ac
tio
n 
(%
)
Figure 3: Effect of Schinus terebinthifolius (St) bark extract, hydrox-
yzine (HXZ), and St + HXZ on the contractions induced by
histamine (1 𝜇M) in isolated guinea pig ileum. Columns and vertical
bars represent the mean ± SEM, respectively (𝑛 = 6). ∗Statistically
different from control. #Significant difference (one-way ANOVA
followed by Tukey’s multiple comparisons test, 𝑝 < 0.05).
groups statistically differed. However, statistical significance
was not verified for the smaller doses and their association.
3.7. Effect of S. terebinthifolius Bark Extract on the Concen-
tration-Effect Curve to 2-Pyridylethylamine. S. terebinthifolius
extract rightward shifted the concentration-effect curves
for 2-PEA in a concentration-dependent manner compared
to the control, with a maximum effect reduction for all
concentrations of the extract (Figure 5). In the presence of
250, 500, and 1,000𝜇g/mL of the extract, the shift was 2.1, 7.1,
and 13.0 times (pEC50 = 5.25± 0.05; 4.79±0.11 and 4.28±0.12,
respectively) that of the control (pEC50 = 5.45 ± 0.04), and
𝐸max reduced from 99.4±0.6%(control) to 70.7±3.3, 35.6±4.3,
and 17.1 ± 2.9% (𝑝 < 0.05), respectively.
3.8. Histamine-Induced Paw Edema in Rats. Table 2 shows
the effect of S. terebinthifolius on acute paw edema induced
by histamine in rats. The maximum phlogistic response of
histamine was observed 1 h after the injection of histamine.
The extract caused a dose-dependent decrease of edema 1 h
after its induction compared to the control group. This effect
was monitored for another 3 h, during which time inhibition
peaked at 53.7, 70.7, and 95.1% (𝑝 < 0.05) in animals
treated with 100, 200, and 400mg/kg of extract, respectively.
The extract in a dose of 400 mg/kg and hydroxyzine (i.e.,
positive control) exhibited equivalent effects in the reduction
of edema since those values were not statistically different.
4. Discussion
Many plant species used in folk medicine induce antihis-
taminic effects by inhibiting histamine release frommast cells
or by blocking the H1 receptor [19–21]. Histamine plays a key
role in many physiological processes, and drugs targeting H1
receptors have been used successfully [22, 23]. In this study,
the possible antihistamine effect of S. terebinthifolius extract
on H1 receptors was evaluated.
Ileum smooth muscle contraction is achieved by com-
plex mechanisms related to a cascade of events involving
several mediators. Together, they culminate in increasing
intracellular calcium concentration [Ca2+]𝑖 as well, which
activates the contraction mechanism.The increase in [Ca2+]𝑖
can be directly induced by plasma membrane depolariza-
tion by depolarizing agents via electromechanical coupling,
includingKCl, which induces calcium influx through voltage-
activated calcium channels (VACCs). Otherwise, it can be
induced by a receptor agonist via pharmacomechanical cou-
pling. Agonists such as histamine and carbachol bind to
G-protein-coupled receptors (𝐺q/11 protein activation) and
activate the phosphoinositide cascade, thereby mediating
the production of inositol 1,4,5-trisphosphate (IP3), which
stimulates calcium release from the sarcoplasmic reticulum,
and diacylglycerol, which, along with calcium, activates the
same protein kinase C that phosphorylates L-type VACCs,
resulting in calcium influx and depolarization. Contractile
agents can also increase [Ca2+]𝑖 through the ryanodine recep-
tor or the induction of calcium influx across the membrane
through various classes of calcium channels [24–26].
Results shown in Figure 2 reveal that S. terebinthifolius
extract selectively inhibited histamine-induced contractions
in a concentration-dependent manner, but it did not exert
any effect on carbachol- or KCl-induced contractions in
guinea pig ileum. It is therefore reasonable to propose that
the extract may act directly on the histaminergic receptor or
in its signaling pathway, since the effect on the muscarinic
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Figure 4: Cumulative concentration-effect curves to histamine in the absence (O) or in the presence of Schinus terebinthifolius bark extract
(St, (a)): 250 (e), 500 (◼), and 1.000 𝜇g/mL (󳵳); hydroxyzine (HXZ, (b)): 0.125 (e) and 0.250 𝜇M (◼); and HXZ + St (c): 250 + 0.125 (e) and
500 𝜇g/mL + 0.250 𝜇M (◼). Symbols and vertical bars represent the mean ± SEM, respectively (𝑛 = 6). ∗Statistically different from control
(one-way ANOVA followed by Tukey’s multiple comparisons test, 𝑝 < 0.05).
(M3) and Ca
2+ influx through VACCs was not altered by the
presence of the extract. Similarly, hydroxyzine, a standard
H1-antihistamine, also caused the inhibition of contractions
induced by histamine but not carbachol or KCl (Figure 3).
Thus, S. terebinthifolius extract exhibits a similar inhibitory
profile of hydroxyzine on the contractile activity in guinea pig
ileum, which suggests an antihistamine effect possibly due to
an action on H1 receptors.
First-generation H1-antihistamines are known to inter-
act with receptors other than H1, including muscarinic
receptors [22]. However, in this study, an inhibitory effect of
hydroxyzine on contractions induced by carbachol on guinea
pig ileum was not observed, which suggests that hydroxyzine
in that concentration does not interfere with the activation of
muscarinic receptors.
The activation of calcium channels is a common mech-
anism involved in contractions induced by histamine, car-
bachol, and KCl. As expected, verapamil, a VACCs blocker,
inhibited contractions induced by the three agents. Such
results indicate that the inhibition caused by S. terebinthifolius
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Table 2: Effect of the oral administration of Schinus terebinthifolius (St) bark extract on paw edema induced by histamine in Wistar rats.
Groups Dose (mg/kg) Edema volume (mL) at different time interval
0.5 h 1 h 2 h 3 h 4 h
Control — 0.26 ± 0.02 0.62 ± 0.03 0.47 ± 0.02 0.44 ± 0.03 0.41 ± 0.03
HXZ 70 0.20 ± 0.01 0.27 ± 0.01 0.15 ± 0.02 0.10 ± 0.02 0.04 ± 0.01
(23.1%) (56.5%)∗ (68.1%)∗ (77.3%)∗ (90,2%)∗
St 100 0.21 ± 0.02 0.41 ± 0.02 0.31 ± 0.02 0.24 ± 0.03 0.19 ± 0.04
(19.2%) (33.9%)∗ (34.0%)∗ (45.5%)∗ (53.7%)∗
St 200 0.22 ± 0.02 0.32 ± 0.03 0.24 ± 0.03 0.18 ± 0.02 0.12 ± 0.02
(15.4%) (48.4%)∗ (48.9%)∗ (59.1%)∗ (70.7%)∗
St 400 0.18 ± 0.03 0.28 ± 0.01 0.17 ± 0.02 0.06 ± 0.01 0.02 ± 0.01
(30.8%) (54.8%)∗ (63.8%)∗ (86.4%)∗ (95.1%)∗
Values represent the mean ± SEM (𝑛 = 3/sex/group). HXZ: hydroxyzine. ∗Statistically different compared to the control. (One-way ANOVA followed by
Tukey’s multiple comparisons test, 𝑝 < 0.05.)
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Figure 5: Cumulative concentration-effect curves to 2-pyridyleth-
ylamine in the absence (O) or in the presence of Schinus terebinthi-
folius (St) bark extract: 250 (e), 500 (◼), and 1,000𝜇g/mL (󳵳).
Symbols and vertical bars represent the mean ± SEM, respectively
(𝑛 = 8). ∗Statistically different from control (one-way ANOVA
followed by Tukey’s multiple comparisons test, 𝑝 < 0.05).
extract does not occur on a common cellular target such as
the VACCs but could be due to a direct action on the H1
receptor, given that contractions induced by carbachol or KCl
did not change in the presence of the extract.
The antihistaminic effect of S. terebinthifolius extract was
also evaluated in association with hydroxyzine (250 𝜇g/mL
+ 0.125 𝜇M or 500 𝜇g/mL + 0.250 𝜇M St + HXZ), to verify
a possible synergic effect (Figure 3). When the drugs were
used simultaneously in both concentrations, an increase
in inhibition occurred that was greater than that of their
administration alone, which suggests a synergic effect.
Gaddum [27] described a useful empirical classification
of receptor antagonisms as surmountable and insurmount-
able antagonisms. A surmountable antagonist produces
dextral displacement (i.e., shifts to the right) of agonist
concentration-response curveswith no concomitant decrease
of the maximal response to the agonist.The standardmethod
of determining the potency of such an antagonist is Schild
analysis or with a Clark plot. A prerequisite of the correct
use of those methods is the demonstration of the parallel
displacement of the agonist concentration-response with no
reduction of maximal response to the agonist. By contrast,
insurmountable antagonists depress the maximal response,
and the determination of potency depends on the model
of antagonism used for data comparison [28]. The most
common explanations for insurmountable antagonisms are
the slow dissociation of the antagonist-receptor complex and
the binding of the antagonist to the allosteric site of the
receptor [29].
At a lower dose (250𝜇g/mL), the extract induced a
parallel shift to the right of the concentration-effect curve to
histamine, thereby suggesting a surmountable antagonism.
However, at higher doses (500 and 1,000 𝜇g/mL), the shift to
the right with a decrease of the maximal effect implied an
insurmountable antagonistic profile.
Interestingly, the pattern of the curve (i.e., shift to the
right, with a decrease of the maximal effect) was similar to
that observed for hydroxyzine. The decrease in the pharma-
cological parameters 𝐸max and pEC50 was even greater when
the extract was associated with hydroxyzine. Such results
suggest an insurmountable antagonism, since the maximal
effect of the concentration-effect curves in the presence of the
extract was reduced.
However, the histamine receptors also presented consti-
tutive activity, defined as the ability to trigger downstream
events even in the absence of a ligand binding. Their active
and inactive states exist in equilibrium; at rest, the inactive
state isomerizes with the active state and vice versa. H1-
antihistamines act as inverse agonists that combine with
and stabilize the inactive conformation of the H1-receptor,
thereby shifting the equilibrium toward the inactive state.
For more than 50 years, they were described as H1-receptor
antagonists or H1-receptor blockers; however, those out-of-
date terms do not accurately reflect their molecular mecha-
nism of action [30].
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To confirm the action of S. terebinthifolius extract on
H1 receptors and eliminate the effect of histamine on other
subtypes of histamine receptors present in the guinea pig
ileum, concentration-effect curves to a H1 selective agonist,
2-pyridylethylamine, was performed in the absence and pres-
ence of the extract. Results showed a decrease in the potency
of 2-pyridylethylamine and a reduction of the maximum
effect in the presence of the extract at all concentrations stud-
ied, which are characteristic of insurmountable antagonisms.
The antihistaminic activity of S. terebinthifolius extract
was also demonstrated in an in vivo assay via the inhibition of
paw edema induced by histamine in rats. Histamine induces
edema primarily through its action on H1 receptors in
vascular tissue. In response to that interaction, vasodilatation
and increased vascular permeability occur, thereby allowing
the extravasation of plasma proteins and intravascular fluid
into the interstitium, with edema formation as a result. In
local inflammatory response, polymorphonuclear leukocyte
infiltration and cytokine release occur [31, 32]. Results of
the present study show that the extract prevented the ede-
matogenic effects produced by histamine, which reinforces
the assumption of the action on the H1 receptor. From
those data, it is possible to infer that the H1-antihistamine
effect of the extract could be useful against allergic processes
triggered by the primary mediator histamine. The leaves of
S. terebinthifolius have been shown to present antiallergic
properties in animal models [12]. Previous studies have
shown that acute and subacute (45-d) oral administration of
S. terebinthifolius bark extract (0.25, 0.625, and 1.5625 g/kg)
did not induce any toxic effects inWistar rats, which indicates
that the extract can be safely administered orally [33].
Based on the results obtained with S. terebinthifolius
extract and considering (i) the selective decrease in
histamine-induced contractions in guinea pig ileum and
lack of effect on the magnitude of contractions induced
by carbachol and KCl, (ii) the inhibitory effect similar
to that exerted by hydroxyzine (H1-antihistamine) but
different from that observed with the VACC verapamil
on contractions induced by histamine, carbachol, and
KCl, (iii) the rightward displacement of all concentration-
effect curves for histamine in a concentration-dependent
manner and the potentiation of the antihistaminic effect
of hydroxyzine in combination with the extract, (iv) the
rightward displacement of all concentration-effect curves
for 2-pyridylethylamine (histamine H1-receptor agonist) in
a concentration-dependent manner, and (v) the decrease
in histamine-induced paw edema in rats, results suggest
that S. terebinthifolius bark extract has antihistaminic
activity and that its probable action mechanism is a direct
interaction with histamine H1 receptors, which constitutes
an insurmountable antagonism.
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